Nowadays, in patients with advanced disease, they are often given in combination with other drugs that are target specific moleculse important for cancer development for instance trastuzumab is a monoclonal antibody targets breast cancers that produce the protein HER2.
Nowadays, in patients with advanced disease, they are often given in combination with other drugs that target specific molecules important for cancer development; for instance, trastuzumab is a monoclonal antibody targeting breast cancers that produce the protein HER2.